BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 20657592)

  • 21. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons.
    Marrs WR; Horne EA; Ortega-Gutierrez S; Cisneros JA; Xu C; Lin YH; Muccioli GG; Lopez-Rodriguez ML; Stella N
    J Biol Chem; 2011 Aug; 286(33):28723-28728. PubMed ID: 21665953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
    Guindon J; Guijarro A; Piomelli D; Hohmann AG
    Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons.
    Keimpema E; Tortoriello G; Alpár A; Capsoni S; Arisi I; Calvigioni D; Hu SS; Cattaneo A; Doherty P; Mackie K; Harkany T
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1935-40. PubMed ID: 23319656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease.
    Kind L; Kursula P
    Amino Acids; 2019 Feb; 51(2):151-174. PubMed ID: 30564946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.
    Zhong P; Pan B; Gao XP; Blankman JL; Cravatt BF; Liu QS
    J Physiol; 2011 Oct; 589(Pt 20):4847-55. PubMed ID: 21911610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina.
    Papadogkonaki S; Spyridakos D; Lapokonstantaki E; Chaniotakis N; Makriyannis A; Malamas MS; Thermos K
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.
    Mulder J; Zilberter M; Pasquaré SJ; Alpár A; Schulte G; Ferreira SG; Köfalvi A; Martín-Moreno AM; Keimpema E; Tanila H; Watanabe M; Mackie K; Hortobágyi T; de Ceballos ML; Harkany T
    Brain; 2011 Apr; 134(Pt 4):1041-60. PubMed ID: 21459826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of monoacylglycerol lipase as novel analgesics.
    Hohmann AG
    Br J Pharmacol; 2007 Mar; 150(6):673-5. PubMed ID: 17293886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action.
    Viader A; Blankman JL; Zhong P; Liu X; Schlosburg JE; Joslyn CM; Liu QS; Tomarchio AJ; Lichtman AH; Selley DE; Sim-Selley LJ; Cravatt BF
    Cell Rep; 2015 Aug; 12(5):798-808. PubMed ID: 26212325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
    Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
    Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    J Neurosci; 2007 Jan; 27(5):1211-9. PubMed ID: 17267577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-induced Neuroinflammation.
    Grabner GF; Eichmann TO; Wagner B; Gao Y; Farzi A; Taschler U; Radner FP; Schweiger M; Lass A; Holzer P; Zinser E; Tschöp MH; Yi CX; Zimmermann R
    J Biol Chem; 2016 Jan; 291(2):913-23. PubMed ID: 26565024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons.
    Dotsey EY; Jung KM; Basit A; Wei D; Daglian J; Vacondio F; Armirotti A; Mor M; Piomelli D
    Chem Biol; 2015 May; 22(5):619-28. PubMed ID: 26000748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
    Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
    J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells.
    Lyons EL; Leone-Kabler S; Kovach AL; Thomas BF; Howlett AC
    Mol Cell Neurosci; 2020 Dec; 109():103566. PubMed ID: 33049367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression.
    Tanimura A; Uchigashima M; Yamazaki M; Uesaka N; Mikuni T; Abe M; Hashimoto K; Watanabe M; Sakimura K; Kano M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12195-200. PubMed ID: 22783023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
    Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
    Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome.
    Thomas G; Betters JL; Lord CC; Brown AL; Marshall S; Ferguson D; Sawyer J; Davis MA; Melchior JT; Blume LC; Howlett AC; Ivanova PT; Milne SB; Myers DS; Mrak I; Leber V; Heier C; Taschler U; Blankman JL; Cravatt BF; Lee RG; Crooke RM; Graham MJ; Zimmermann R; Brown HA; Brown JM
    Cell Rep; 2013 Oct; 5(2):508-20. PubMed ID: 24095738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.